Ani Sinha: Driving Commercial Transformation in the Age of AI
Leading Minds by Life Sciences Voice
Release Date: 10/08/2025
Leading Minds by Life Sciences Voice
In this episode, host Jasmeet Sawhney engages with Anindita (Ani) Sinha, a visionary leader in the pharmaceutical and biotechnology industries. As Vice President of Commercial Operations at Shionogi U.S., Ani brings a wealth of experience in analytics, market research, and field management. She shares her inspiring transition from academia to pharma leadership, offering actionable advice on harnessing data, driving commercial success, and navigating change with the aid of AI and technology. Her passion for building cohesive teams and aligning them to a common truth makes this a must-listen for...
info_outlineLeading Minds by Life Sciences Voice
On this episode, host Jasmeet Sawhney sits down with Dr. Alexandra Goncalves, VP and Head of Digital Health at Bristol Myers Squibb, to explore how a lifelong learner thrives at the intersection of clinical medicine, technology, and innovation. From leveraging AI in clinical trials to championing personalized medicine and remote patient monitoring, Alexandra shares her bold career moves, her approach to leadership, and how she creates space for continuous growth, even in the busiest of schedules. IN THIS EPISODE: (03:18) Alexandra shares a snapshot of her professional career, making...
info_outlineLeading Minds by Life Sciences Voice
In this episode of Leading Minds, host Jasmeet Sawhney sits down with Johanna Rossell, SVP and GM Rare Disease at Sumitomo Pharma America, Inc., to explore the evolving landscape of biotech and rare disease treatment. They discuss the critical need for collaboration across the entire healthcare ecosystem—including the FDA, healthcare providers, and researchers—to ensure life-changing therapies reach patients in time. Johanna shares her passion for patient impact, the power of data in demonstrating treatment value, and the importance of breaking traditional silos in pharma to drive...
info_outlineLeading Minds by Life Sciences Voice
In this episode of Leading Minds, host Jasmeet Sawhney sits down with Nuray Yurt, the Head of Integrated Research and Forecasting at Merck and PMSA President, to discuss the evolving role of AI and analytics in the pharmaceutical industry. Nuray shares her insights on how Merck is leveraging AI to drive innovation in analytical processes, including forecasting and market research, and emphasizing the importance of integrating AI into core capabilities rather than treating it as a separate function. Together, they explore the progress of pharma in the AI hype cycle, the challenges of...
info_outlineLeading Minds by Life Sciences Voice
On this episode of the Leading Minds, hosted by Jasmeet Sawhney, Jassi Chadha, President and CEO of Axtria, and Paul Bedard, Senior Vice President of Customer Engagement at Bayer US, dive into how customer-centric models are reshaping healthcare. Paul discusses Bayer’s implementation of Dynamic Shared Ownership (DSO), a transformative approach where teams work in 90-day cycles, focusing on outcomes and giving individuals autonomy to drive results. Jassi expands on how digital technology and data analytics are critical in refining customer engagement and utilizing AI to provide physicians...
info_outlineLeading Minds by Life Sciences Voice
Join us for an insightful discussion with Michael Bailey, CEO of AVEO Oncology. Michael and Jasmeet delve into the realities of career growth, exploring both the triumphs and setbacks. Michael, a strong advocate for active listening, shares how this skill empowers leaders. He'll discuss the common pitfalls of aspiring leaders feeling pressure to climb the ladder quickly, which leads to taking shortcuts or neglecting a solid foundation, ultimately hindering long-term success. Michael also introduces his concept of the five E's of life and career. Don't miss this valuable episode packed with...
info_outlineLeading Minds by Life Sciences Voice
Today, we are honored to have Gurdyal Kalsi as our guest, holding the position of Chief Medical Officer at Asklepion Pharma and AdventHealth and overseeing a varied Research and Development portfolio. Gurdyal explores the significance of AI in healthcare and emphasizes a long-overdue shift toward giving patients a voice in clinical trials. He underscores the necessity of addressing illnesses and striving for a definitive cure, which he terms "One and Done." Additionally, Gurdyal provides insights into the future direction of the life science field and emphasizes the role AI is poised to play...
info_outlineLeading Minds by Life Sciences Voice
Today, we have the privilege of hosting Ramona Sequeira, the President of Takeda's Global Portfolio Division. She will delve into Takeda's involvement in the Life Science sector, shedding light on leadership, employee oversight, and recruitment. Ramona emphasizes three essential qualities for those aspiring to join her team: curiosity, humility, and courage. Additionally, she delves into the importance of making decisions as close to the patient as possible, tailoring strategies to the needs of specific healthcare systems and markets. IN THIS EPISODE: [03:56] Ramona provides a...
info_outlineLeading Minds by Life Sciences Voice
Jaswinder (Jassi) Chadha, President and CEO of Axtria, which is one of the life sciences' most prominent global leaders, joins us today to discuss how innovation has transformed the global healthcare system. He is regarded as one of the top data scientists and influential thought leaders in the life sciences industry. Jaswinder will share his perspective on the fast-growing and ever-changing life sciences industry, including how Covid created a recognition in pharma of the human-centric aspects of healthcare. In addition, Jassi shares how he balances his busy work schedule with family...
info_outlineLeading Minds by Life Sciences Voice
Dr. Devyn Smith, the CEO of Arbor Biotechnologies, one the leading companies today, joins us to discuss cutting and rewriting sections of DNA so that you can replace mutations. This industry is changing daily, and it’s exciting to think that a small molecule and antibody can treat a disease. However, with cell and gene therapies, the industry is moving beyond treatment to thinking about curative approaches. The focus is on curing or treating genetic diseases ALS or Huntington's. Listen in to learn about these revolutionary therapies. IN THIS EPISODE: [03:08] Devyn shares his...
info_outlineIn this episode, host Jasmeet Sawhney engages with Anindita (Ani) Sinha, a visionary leader in the pharmaceutical and biotechnology industries. As Vice President of Commercial Operations at Shionogi U.S., Ani brings a wealth of experience in analytics, market research, and field management. She shares her inspiring transition from academia to pharma leadership, offering actionable advice on harnessing data, driving commercial success, and navigating change with the aid of AI and technology. Her passion for building cohesive teams and aligning them to a common truth makes this a must-listen for anyone aiming to shape the future of the industry.
IN THIS EPISODE:
-
(03:15) Explains shift from academia to pharma, driven by a love for problem-solving
-
(06:00) Pioneering analytics in market access, empowering data-driven decisions
-
(11:42) External data trends in the pharma industry, emphasizing the need to ingest and analyze data
-
(15:48) Discussion of commercial organizations evolving and of the utilization of AI
-
(22:17) Importance of change management and Agile methodology
-
(26:18) Knowing team strengths and advising upcoming and senior leadership
-
(32:51) How to continue learning and balance both personal and professional time
-
(39:22) Jasmeet asks Anindita rapid-fire questions
KEY TAKEAWAYS:
-
Align to a Common Truth: Ani emphasizes the importance of aligning teams across commercial operations, including analytics, market research, and field operations, to a shared, data-driven truth. Doing so enhances cohesion and drives effective strategy in the pharmaceutical and biotech industries.
-
Leverage AI as a Tool: AI and technology should be used to solve specific problems, improving efficiency and insights in commercial functions, but only after clearly defining the goal. This ensures transformation is purposeful and impactful.
-
Foster Curiosity and Drive Change: Building a culture of curiosity and effective change management helps teams adopt new data methods and leadership approaches. Nurturing this mindset prepares them for the evolving pharmaceutical landscape.
RESOURCE LINKS:
Anindita (Ani) Sinha - Vice President @ Shionogi - LinkedIn
BIOGRAPHIES:
YOUR HOST:
Jasmeet Sawhney is a life sciences industry executive, marketing leader, and serial entrepreneur with deep roots in technology and data analytics. He is currently the global head of marketing at Axtria. Jasmeet has over 20 years of experience in life sciences and has helped build and scale three successful companies. He has received several company and individual awards, including Inc. 500, Deloitte Fast 500, Crain’s NY Fast 50, NJBiz Fast 50, Business of the Year, SmartCEO Future 50, Top CMO, Forty Under 40, and many more.
GUEST:
Anindita Sinha is Vice President of Commercial Operations at Shionogi U.S., bringing 15 years of high-level expertise in pharmaceuticals and biotech. She is recognized for her strategic vision and ability to identify growth opportunities, boost operational efficiency, and lead business development and brand launches. Her track record includes executive roles in both large pharma and startups, driving revenue and building strong alignment among executive teams, stakeholders, and staff. Anindita is passionate about applying analytics to inform strategy and enable data-driven decisions, ultimately leading to improved patient outcomes and business results.